Science

AddToAny

Google+ Facebook Twitter Twitter

IBMS research grants 2021

The five recipients of the IBMS research grants in 2021 introduce us to their research projectsnand discuss what impact their work could have.
 

The IBMS awards research funding to members to support novel work and spur innovations in diagnostics, prognostics and the treatment of disease. This year, we awarded research grants of over £22,000 to fund five original projects in biomedical science. They range from researching new ways

to overcome life-threatening infections in cystic fibrosis patients, to identifying new biomarkers to transform how we diagnose prostate cancer and help prevent tragic cases of spontaneous abortion. We’ve also sponsored work investigating the health risks of e-smoking and a project endeavouring to develop new vaccines that are administered orally and powered by yeast. Here, the five recipients outline their projects.

Robert Reilly

Blood Transfusion Manager and Chief Biomedical Scientist, Maidstone and Tunbridge Wells NHS Trust

Determination of a panel of systemic markers for women with recurrent pregnancy loss (RPL) of unknown (idiopathic) cause (a pilot study)

Approximately 15% of all clinically recognised pregnancies in women under 35 result in spontaneous pregnancy loss; the current international definition of recurrent pregnancy loss (RPL) applies to couples who experience two or more pregnancy losses with or without previous live births. Apart from the emotional trauma suffered by affected couples, there is also a financial impact on both the National Health Service (NHS) for treatment of the mother and evaluation of the foetus and the economy through lost time in the workplace caused by stress. Therefore, this is an important but challenging area to study.

It has been recognised that approximately 50% of all losses are of known or diagnosed causes. The remaining 50% remain unclear (idiopathic RPL), with no apparent genetic abnormality in either parent. Literature has suggested that the reason may be multifactorial, with no single factor convincingly being associated with RPL to date.

Please click here to read the full article.

Image credit | IBMS | Shutterstock

Related Articles

Genes identified to potentially diagnose Lyme disease

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease.

The HSD developing specialist skills

Specialist Biomedical Scientist Naveed Sadia outlines her preparations for the Higher Specialist Diploma and her hopes for how it will benefit her career.

My lab: specialist testing services

Phil Cummings, Training Manager, and Herbert Tsuro, Project Lead, give a guided tour of blood transfusion laboratories in Leeds.

Three placements

Elesha George, a fourth-year student at Aberdeen’s Robert Gordon University, talks through a year of very different placements.

Top